Kathryn Carr Payne
Directeur/Bestuurslid bij Massachusetts Biotechnology Council
Profiel
Kathryn Carr Payne is currently the Director at Massachusetts Biotechnology Council and Director at March of Dimes Chapter.
She previously worked as Vice President at APCO Worldwide LLC, Vice President-External Affairs at AMAG Pharmaceuticals, Inc., Communications Associate at The World Bank, and Senior VP-Communications & External Affairs at Orchard Therapeutics Plc.
Ms. Payne completed her undergraduate and graduate degrees at The Johns Hopkins University.
Actieve functies van Kathryn Carr Payne
Bedrijven | Functie | Begin |
---|---|---|
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Directeur/Bestuurslid | - |
March of Dimes Chapter | Directeur/Bestuurslid | - |
Eerdere bekende functies van Kathryn Carr Payne
Bedrijven | Functie | Einde |
---|---|---|
AMAG PHARMACEUTICALS, INC. | Public Communications Contact | 01-08-2018 |
The World Bank | Public Communications Contact | - |
ORCHARD THERAPEUTICS PLC | Public Communications Contact | - |
APCO Worldwide LLC
APCO Worldwide LLC Miscellaneous Commercial ServicesCommercial Services APCO Worldwide LLC engages in the provision of advisory and advocacy communications consultancy solutions. It offers communications, public affairs, government relations, legal, risk, organizational transformation, international relations, corporate responsibility, and brand marketing services. The company was founded by Margery Kraus in 1984 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Opleiding van Kathryn Carr Payne
The Johns Hopkins University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 6 |
---|---|
APCO Worldwide LLC
APCO Worldwide LLC Miscellaneous Commercial ServicesCommercial Services APCO Worldwide LLC engages in the provision of advisory and advocacy communications consultancy solutions. It offers communications, public affairs, government relations, legal, risk, organizational transformation, international relations, corporate responsibility, and brand marketing services. The company was founded by Margery Kraus in 1984 and is headquartered in Washington, DC. | Commercial Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
The World Bank | Government |
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
March of Dimes Chapter |